During the past decade, Florida Urology Partners conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 10 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 6 clinical trials were completed. i.e. 31.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Urology Partners" #1 sponsor was "Ferring Pharmaceuticals" with 5 trials, followed by "MedtronicNeuro" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Myovant Sciences GmbH" with 2 trials sponsored and "Urovant Sciences GmbH" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Urology Partners" #1 collaborator was "ClinLogix. LLC" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Florida Urology Partners" are "Prostate Cancer" (9 trials), "Overactive Bladder" (4 trials), "Urinary Urge Incontinence" (3 trials), "Benign Prostatic Hyperplasia" (2 trials) and "Fecal Incontinence" (2 trials). Many other conditions were trialed in "Florida Urology Partners" in a lesser frequency.

Most popular intervention types in "Florida Urology Partners" are "Drug" (19 trials), "Device" (11 trials), "Biological" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Degarelix" (2 trials), "Leuprolide" (2 trials), "Relugolix" (2 trials) and "Vibegron" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florida Urology Partners" are 16 trials for "Male" genders, 13 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Florida Urology Partners". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Florida Urology Partners, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Urology Partners, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".